摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1-Isobutylcyclobutyl)methanol | 433219-79-5

中文名称
——
中文别名
——
英文名称
(1-Isobutylcyclobutyl)methanol
英文别名
[1-(2-methylpropyl)cyclobutyl]methanol
(1-Isobutylcyclobutyl)methanol化学式
CAS
433219-79-5
化学式
C9H18O
mdl
——
分子量
142.241
InChiKey
ATZAVHXCGFSBKK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    180.6±8.0 °C(Predicted)
  • 密度:
    0.894±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1-Isobutylcyclobutyl)methanol2,6-二甲基吡啶草酰氯偶氮二异丁腈氢氟酸叔丁基锂三正丁基氢锡magnesium二甲基亚砜 、 lithium,azanidylidenemethylidenecopper,2H-thiophen-2-ide 、 三乙胺 、 mercury dichloride 作用下, 以 四氢呋喃乙醚二氯甲烷乙腈正戊烷 为溶剂, 反应 7.51h, 生成
    参考文献:
    名称:
    Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives
    摘要:
    Design and synthesis of an EP2-receptor selective agonist began with the chemical modification of alpha- and omega-chains of butaprost 1a, which exhibits an affinity for the IP-receptor. Two series of prostaglandin (PG) analogues with a 16-hydroxy-17,17-trimethylene moiety as an omega-chain were identified. Among those tested, 4a,b,e,f,h and 6a,b,e,f,h were found to be highly selective EP2-receptor agonists. Structure activity relationships are discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(01)00369-8
  • 作为产物:
    描述:
    环丁基甲酸 在 lithium aluminium tetrahydride 、 lithium diisopropyl amide 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 15.5h, 生成 (1-Isobutylcyclobutyl)methanol
    参考文献:
    名称:
    Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives
    摘要:
    Design and synthesis of an EP2-receptor selective agonist began with the chemical modification of alpha- and omega-chains of butaprost 1a, which exhibits an affinity for the IP-receptor. Two series of prostaglandin (PG) analogues with a 16-hydroxy-17,17-trimethylene moiety as an omega-chain were identified. Among those tested, 4a,b,e,f,h and 6a,b,e,f,h were found to be highly selective EP2-receptor agonists. Structure activity relationships are discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(01)00369-8
点击查看最新优质反应信息

文献信息

  • Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
    申请人:Bellenie Benjamin Richard
    公开号:US10004732B2
    公开(公告)日:2018-06-26
    The present invention provides compounds of formula (I) which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.
    本发明提供了抑制 PI 3-kinase gamma 异构体活性的式 (I) 化合物,可用于治疗由 PI 3-kinase gamma 异构体活化介导的疾病。
  • AMINO PYRAZINE DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
    申请人:BELLENIE Benjamin Richard
    公开号:US20170042889A1
    公开(公告)日:2017-02-16
    The present invention provides compounds of formula (I) which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.
  • 2-(PYRAZIN-2-YLCARBONYLAMINOMETHYL) BENZIMIDAZOLIUM COMPOUNDS AS EPITHELIAL SODIUM CHANNEL INHIBITORS
    申请人:Boehringer Ingelheim International GmbH
    公开号:US20180002314A1
    公开(公告)日:2018-01-04
    The present invention relates to compounds of formula (I) or the tautomers or pharmacologically acceptable acid addition salts thereof, characterized by a topological polar surface area value (TPSA) of at least 145, wherein R 1 , R 2 , R 3 , R 4 , X, and Z − have one of the meanings as defined in the specification, to the use of compounds of formula (I) as medicaments, to pharmaceutical compositions comprising at least one compound of formula (I), as well as to medicament combinations containing one or more compounds of formula (I). The compounds are ENaC inhibitors useful for the treatment of respiratory diseases and allergic diseases of the airways.
  • US9981954B2
    申请人:——
    公开号:US9981954B2
    公开(公告)日:2018-05-29
  • Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives
    作者:Kousuke Tani、Atsushi Naganawa、Akiharu Ishida、Kenji Sagawa、Hiroyuki Harada、Mikio Ogawa、Takayuki Maruyama、Shuichi Ohuchida、Hisao Nakai、Kigen Kondo、Masaaki Toda
    DOI:10.1016/s0968-0896(01)00369-8
    日期:2002.4
    Design and synthesis of an EP2-receptor selective agonist began with the chemical modification of alpha- and omega-chains of butaprost 1a, which exhibits an affinity for the IP-receptor. Two series of prostaglandin (PG) analogues with a 16-hydroxy-17,17-trimethylene moiety as an omega-chain were identified. Among those tested, 4a,b,e,f,h and 6a,b,e,f,h were found to be highly selective EP2-receptor agonists. Structure activity relationships are discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多